Psychosocial and quality of life in women receiving the 21-gene recurrence score assay: The impact of decision style in women with intermediate RS

Journal of Cancer Epidemiology

Volumn , Issue , 2012, Pages

  Sulayman, Nadiyah ^a   Spellman, Elizabeth ^a   Graves, Kristi D ^a   Peshkin, Beth N ^a   Isaacs, Claudine ^a   Schwartz, Marc D ^a   Oneill, Suzanne C ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

21 GENE RECURRENCE SCORE ASSAY; ARTICLE; BREAST CANCER; CONFLICT; CROSS-SECTIONAL STUDY; DISTRESS SYNDROME; FEMALE; GENETIC PROCEDURES; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PASSIVE DECISION MAKING; PATIENT DECISION MAKING; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RETROSPECTIVE STUDY; SHARED DECISION MAKING; SOCIAL PSYCHOLOGY;

EID: 84864922012     PISSN: 16878558     EISSN: 16878566     Source Type: Journal    
DOI: 10.1155/2012/728290     Document Type: Article

References (52)

1. Olopade O. I., Grushko T. A., Nanda R., Huo D., Advances in breast cancer: pathways to personalized medicine Clinical Cancer Research 2008 14 24 7988 7999
2. Harris L., Fritsche H., Mennel R., Norton L., Ravdin P., Taube S., Somerfield M. R., Hayes D. F., Bast R. C., American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer Journal of Clinical Oncology 2007 25 33 5287 5312 (Pubitemid 350232263)
3. Ben-Baruch N., Hammerman A., Klang S., Liebermann N., A prospective study of the impact of the 21-gene recurrence score assay on treatment decisions in N-, ER+ early stage breast cancer patients Journal of Clinical Oncology 2007 25 18, abstract 1108
4. National Comprehensive Cancer Network,. NCCN Clinical Practice Guidelines in Oncology. Breast Cancer. Version 1, 2012, http://www.nccn.org/professionals/ physiciangls/pdf/breast.pdf
5. Mamounas E. P., Tang G., Fisher B., Paik S., Shak S., Costantino J. P., Watson D., Geyer C. E., Wickerham D. L., Wolmark N., Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20 Journal of Clinical Oncology 2010 28 10 1677 1683
6. Paik S., Tang G., Shak S., Kim C., Baker J., Kim W., Cronin M., Baehner F. L., Watson D., Bryant J., Costantino J. P., Geyer C. E., Wickerham D. L., Wolmark N., Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer Journal of Clinical Oncology 2006 24 23 3726 3734 (Pubitemid 46622311)
7. Sparano J. A., Paik S., Development of the 21-gene assay and its application in clinical practice and clinical trials Journal of Clinical Oncology 2008 26 5 721 728 (Pubitemid 351264384)
8. Pieterse A. H., Henselmans I., de Haes H. C. J. M., Koning C. C. E., Geijsen E. D., Smets E. M. A., Shared decision making: prostate cancer patients' appraisal of treatment alternatives and oncologists' eliciting and responding behavior, an explorative study Patient Education and Counseling 2011 85 3 e251 e259
9. Sidana A., Hernandez D. J., Feng Z., Partin A. W., Trock B. J., Saha S., Epstein J. I., Treatment decision-making for localized prostate cancer: what younger men choose and why Prostate 2012 72 1 58 64
10. Albanell J., Gonzalez A., Ruiz-Borrego M., Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer Annals of Oncology 2012 23 3 625 631
11. Asad J., Jacobson A. F., Estabrook A., Smith S. R., Boolbol S. K., Feldman S. M., Osborne M. P., Boachie-Adjei K., Twardzik W., Tartter P. I., Does oncotype DX recurrence score affect the management of patients with early-stage breast cancer? American Journal of Surgery 2008 196 4 527 529
12. Geffen D. B., Abu-Ghanem S., Sion-Vardy N., The impact of the 21-gene recurrence score assay on decision making about adjuvant chemotherapy in early-stage estrogen-receptor-positive breast cancer in an oncology practice with a unified treatment policy Annals of Oncology 2011 22 11 2381 2386
13. Henry L. R., Stojadinovic A., Swain S. M., Prindiville S., Cordes R., Soballe P. W., The influence of a gene expression profile on breast cancer decisions Journal of Surgical Oncology 2009 99 6 319 323
14. Partin J. F., Mamounas E. P., Impact of the 21-gene recurrence score assay compared with standard clinicopathologic guidelines in adjuvant therapy selection for node-negative, estrogen receptor-positive breast cancer Annals of Surgical Oncology 2011 18 12 3399 3406
15. Oratz R., Paul D., Cohn A. L., Sedlacek S. M., Impact of a commercial reference laboratory test recurrence score on decision making in early-stage breast cancer Journal of Oncology Practice 2007 3 4 182 186 (Pubitemid 351593669)
16. Rayhanabad J. A., Difronzo L. A., Haigh P. I., Romero L., Changing paradigms in breast cancer management: introducing molecular genetics into the treatment algorithm American Surgeon 2008 74 10 887 890
17. Lo S. S., Mumby P. B., Norton J., Rychlik K., Smerage J., Kash J., Chew H. K., Gaynor E. R., Hayes D. F., Epstein A., Albain K. S., Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection Journal of Clinical Oncology 2010 28 10 1671 1676
18. Brewer N. T., Richman A. R., Defrank J. T., Reyna V. F., Carey L. A., Improving communication of breast cancer recurrence risk Breast Cancer Research and Treatment 2012 133 2 553 561
19. Tzeng J. P., Mayer D., Richman A. R., Lipkus I., Han P. K., Valle C. G., Carey L. A., Brewer N. T., Women's experiences with genomic testing for breast cancer recurrence risk Cancer 2010 116 8 1992 2000
20. Brown R., Butow P., Wilson-Genderson M., Bernhard J., Ribi K., Juraskova I., Meeting the decision-making preferences of patients with breast cancer in oncology consultations: impact on decision-related outcomes Journal of Clinical Oncology 2012 30 8 857 862
21. Gattellari M., Butow P. N., Tattersall M. H. N., Sharing decisions in cancer care Social Science and Medicine 2001 52 12 1865 1878 (Pubitemid 32463336)
22. Andersen M. R., Bowen D. J., Morea J., Stein K. D., Baker F., Involvement in Decision-Making and Breast Cancer Survivor Quality of Life Health Psychology 2009 28 1 29 37
23. Hack T. F., Degner L. F., Watson P., Sinha L., Do patients benefit from participating in medical decision making? Longitudinal follow-up of women with breast cancer Psycho-Oncology 2006 15 1 9 19 (Pubitemid 43141514)
24. Hack T. F., Pickles T., Ruether J. D., Weir L., Bultz B. D., Mackey J., Degner L. F., Predictors of distress and quality of life in patients undergoing cancer therapy: impact of treatment type and decisional role Psycho-Oncology 2010 19 6 606 616
25. Taking shared decision making more seriously Lancet 2011 377 9768 784
26. Barratt A., Evidence based medicine and shared decision making: the challenge of getting both evidence and preferences into health care Patient Education and Counseling 2008 73 3 407 412
27. Ravdin P. M., Siminoff L. A., Davis G. J., Mercer M. B., Hewlett J., Gerson N., Parker H. L., Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer Journal of Clinical Oncology 2001 19 4 980 991 (Pubitemid 32176272)
28. Siminoff L. A., Gordon N. H., Silverman P., Budd T., Ravdin P. A., A decision aid to assist in adjuvant therapy choices for breast cancer Psycho-Oncology 2006 15 11 1001 1013 (Pubitemid 44762705)
29. Degner L. F., Russell C. A., Preferences for treatment control among adults with cancer Research in Nursing Health 1988 11 6 367 374
30. Degner L. F., Kristjanson L. J., Bowman D., Sloan J. A., Carriere K. C., O'Neil J., Bilodeau B., Watson P., Mueller B., Information needs and decisional preferences in women with breast cancer Journal of the American Medical Association 1997 277 18 1485 1492 (Pubitemid 27208893)
31. Horowitz M., Wilner N., Alvarez W., Impact of event scale: a measure of subjective stress Psychosomatic Medicine 1979 41 3 209 218 (Pubitemid 9219271)
32. Lerman C., Trock B., Rimer B. K., Jepson C., Brody D., Boyce A., Psychological side effects of breast cancer screening Health Psychology 1991 10 4 259 267
33. Brady M. J., Cella D. F., Mo F., Bonomi A. E., Tulsky D. S., Lloyd S. R., Deasy S., Cobleigh M., Shiomoto G., Reliability and validity of the functional assessment of cancer therapy- breast quality-of-life instrument Journal of Clinical Oncology 1997 15 3 974 986 (Pubitemid 27106280)
34. O'Connor A. M., Validation of a decisional conflict scale Medical Decision Making 1995 15 1 25 30
35. Horowitz M., Goldberger L., Breznitz S., Stress response syndromes and their treatment Handbook of Stress: Theoretical and Clinical Aspects 1982 New York, NY, USA Free Press 209 218
36. Avis N. E., Crawford S., Manuel J., Quality of life among younger women with breast cancer Journal of Clinical Oncology 2005 23 15 3322 3330
37. O'Neill S. C., Rini C., Goldsmith R. E., Valdimarsdottir H., Cohen L. H., Schwartz M. D., Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes Psycho-Oncology 2009 18 10 1088 1096
38. Braithwaite D., Emery J., Walter F., Prevost A. T., Sutton S., Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis Journal of the National Cancer Institute 2004 96 2 122 133 (Pubitemid 38195903)
39. Hamilton J. G., Lobel M., Moyer A., Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review Health Psychology 2009 28 4 510 518
40. Hilgart J. S., Coles B., Iredale R., Cancer genetic risk assessment for individuals at risk of familial breast cancer Cochrane Database of Systematic Reviews 2007 2
41. Rini C., O'Neill S. C., Valdimarsdottir H., Goldsmith R. E., Jandorf L., Brown K., DeMarco T. A., Peshkin B. N., Schwartz M. D., Cognitive and emotional factors predicting decisional conflict among high-risk breast cancer survivors who receive uninformative BRCA1/2 results Health Psychology 2009 28 5 569 578
42. Brownlee S., Wennberg J. E., Barry M. J., Fisher E. S., Goodman D. C., Bynum J. P. W., Improving patient decision-making in health care: a 2011 Dartmouth Atlas report highlighting Minnesota. http://www.dartmouthatlas.org/ downloads/reports/Decisionmakingreport022411.pdf
43. Katz S. J., Lantz P. M., Janz N. K., Fagerlin A., Schwanz R., Liu L., Deapen D., Salem B., Lakhani I., Morrow M., Patient involvement in surgery treatment decisions for breast cancer Journal of Clinical Oncology 2005 23 24 5526 5533
44. Lantz P. M., Janz N. K., Fagerlin A., Schwartz K., Liu L., Lakhani I., Salem B., Katz S. J., Satisfaction with surgery outcomes and the decision process in a population-based sample of women with breast cancer Health Services Research 2005 40 3 745 767 (Pubitemid 40791614)
45. Lea D. H., Kaphingst K. A., Bowen D., Lipkus I., Hadley D. W., Communicating genetic and genomic information: health literacy and numeracy considerations Public Health Genomics 2011 14 4-5 279 289
46. Hawley S. T., Lantz P. M., Janz N. K., Salem B., Morrow M., Schwartz K., Liu L., Katz S. J., Factors associated with patient involvement in surgical treatment decision making for breast cancer Patient Education and Counseling 2007 65 3 387 395 (Pubitemid 46241780)
47. Waljee J. F., Rogers M. A. M., Alderman A. K., Decision aids and breast cancer: do they influence choice for surgery and knowledge of treatment options? Journal of Clinical Oncology 2007 25 9 1067 1073 (Pubitemid 46596758)
48. Gong H. S., Huh J. K., Lee J. H., Kim M. B., Chung M. S., Baek G. H., Patients' preferred and retrospectively perceived levels of involvement during decision-making regarding carpal tunnel release Journal of Bone and Joint Surgery Series A 2011 93 16 1527 1533
49. Hawley S. T., Griggs J. J., Hamilton A. S., Graff J. J., Janz N. K., Morrow M., Jagsi R., Salem B., Katz S. J., Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients Journal of the National Cancer Institute 2009 101 19 1337 1347
50. Lee C. N., Chang Y., Adimorah N., Belkora J. K., Moy B., Partridge A. H., Ollila D. W., Sepucha K. R., Decision making about surgery for early-stage breast cancer Journal of the American College of Surgeons 2012 214 1 1 10
51. Dowsett M., Cuzick J., Wale C., Forbes J., Mallon E. A., Salter J., Quinn E., Dunbier A., Baum M., Buzdar A., Howell A., Bugarini R., Baehner F. L., Shak S., Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study Journal of Clinical Oncology 2010 28 11 1829 1834
52. Oratz R., Kim B., Chao C., Skrzypczak S., Ory C., Bugarini R., Broder M., Physician survey of the effect of the 21-gene recurrence score assay results on treatment recommendations for patients with lymph node-positive, estrogen receptor-positive breast cancer Journal of Oncology Practice 2011 7 2 94 99